Effects of human immunodeficiency virus type 1 on CD4 lymphocyte subset activation

European Journal of Immunology

Volumn 29, Issue 6, 1999, Pages 1879-1889

  Masci, Anna Maria ^a   Paz, Francisca Lago ^a   Borriello, Adriana ^b   Cassano, Silvana ^a   Della Pietra, Valentina ^b   Stoiber, Heribert ^c   Matarese, Giuseppe ^a   Della Ragione, Fulvio ^b   Zappacosta, Serafino ^a   Racioppi, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

cAMP; HIV 1; Lymphocyte activation; Naive lymphocyte; Protein kinase A

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHOTYROSINE; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS PARTICLE;

ANTIGENS, CD45; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CD4-POSITIVE T-LYMPHOCYTES; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME ACTIVATION; HEAT; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; PHOSPHOTYROSINE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 6544235275     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199906)29:06<1879::AID-IMMU1879>3.0.CO;2-2     Document Type: Article

References (49)

1. Pantaleo, G. and Fauci, A. S., New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 1995. 13: 487-512.
2. Hellerstein, M. K. and McCune, J. M., T cell turnover in HIV-1 disease. Immunity 1997. 7: 583-589.
3. Wolthers, K. C., Schuitemaker, H. and Miedema, F., Rapid CD4+ T-cell turnover in HIV-1 infection: a paradigm revisited. Immunol. Today 1998. 19: 44-48.
4. Rosenberg, Y. J., Anderson, A. O. and Pabst, R., HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol. Today 1998. 19: 10-17.
5. Sprent, J., Life span of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 1997. 9: 433-438.
6. Farber, D. L., Acuto, O. and Bottomly, K., Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur. J. Immunol. 1997. 27: 2094-2101.
7. Kimachi, K., Croft, M. and Grey, H. M., The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells. Eur. J. Immunol. 1997. 27: 3310-3317.
8. Iezzi, G., Karjalainen, K. and Lanzavecchia, A., The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998. 8: 89-95..
9. Marelli-Berg, F. M., Hargreaves, R. E., Carmichael, P., Dorling, A., Lombardi, G. and Lechler, R. I., Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J. Exp. Med. 1996. 183: 1603-1612.
10. Hoy, J. F., Lewis, D. E. and Miller, G. G., Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro responses to Cryptococcus neoformans. J. Infect Dis. 1988. 158: 1071-1078.
11. Bentin, J., Tsoukas, C. D., Mc Cutchan, J. A., Spector, S. A., Richman, D. D. and Vaughan, J. H., Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus. J. Clin. Immunol. 1989. 9: 159-168.
12. Gruters, R. A., Terpstra, F. G., De Jong, R., Van Noesel, C. J., Van Lier, R. A. and Miedema, F., Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 1990. 20: 1039-1044.
13. Meyaard, L, Otto, S. A., Hooibrink, B. and Miedema, F., Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection: gradual decline of both naive and memory alloreactive T cells, J. Clin. Invest. 1994. 94: 1947-1952..
14. Hofmann, B., Jakobsen, K. D., Odum, N. et al., HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. J. Immunol. 1989. 142: 1874-1880.
15. Shearer, G. M. and Clerici, M., Early T-helper cell defects in HIV infection [editorial]. AIDS 1991. 5: 245-253.
16. Lane, H. C., Depper, J. M., Greene, W. C., Whalen, G., Waldmann, T. A. and Fauci, A. S., Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 1985. 313: 79-84.
17. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, V. and Shearer, C. S., Detection of three distinct patterns of T helper cell dysfunction in asymptomatik, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 1989. 84: 1892-1899.
18. Chou, C. C., Gudeman, V., O'Rourke, S., Isacescu, V., Detels, R., Williams, G. J., Mitsuyasu, R. T. and Giorgi, J. V., Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease. J. Acquir. Immune Defic. Syndr. 1994. 7: 665-675.
19. Schnittman, S. M., Lane, H. C., Greenhouse, J., Justement, J. S., Baseler, J. S. and Fauci, A. S., Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA 1990. 87: 6058-6062.
20. van Noesel, C. J., Gruters, R. A. R., Terpstra, F. G., Schellekens, P. T., van Lier, R. A. and Miedema, F., Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 1990. 86: 293-299.
21. Cayota, A., Vuillier, F., Scott-Algara, D., Feuillie, V. and Dighiero, G., Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients. Clin. Exp. Immunol. 1992. 88: 478-483.
22. Rabin, R. L., Roederer, M., Maldonado, Y., Petru, A. and Herzenberg, L. A., Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J. Clin. Invest. 1995. 95: 2054-2060.
23. Roederer, M., Dubs, J. G., Anderson, M. T., Raju, P. A. and Herzenberg, L. A., CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 1995. 95: 2061-2066.
24. Connors, M., Kovacs, J. A., Krevat, S., Gea-Banacloche, J. C., Sneller, M. C., Flanigan, M., Metcalf, J. A., Walker, R. E., Falloon, J., Baseler, M., Feuerstein, I., Masur, H. and Lane, H. C., HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 1997. 3: 533-540.
25. Woods, T. C., Roberts, B. D., Butera, S. T. and Folks, T. M., Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 1997. 89: 1635-1641.
26. Chun, T. W., Chadwick, K., Margolick, J. and Siliciano, R. F., Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. J. Virol. 1997. 71: 4436-4444.
27. Hofmann, B., Nishanian, P., Baldwin, R. L., Insixiengmay, R. L., Nel, A. and Fahey, J. L., HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J. Immunol. 1990. 145: 3699-3705.
28. Pelech, S. L. and Sanghera, J. S., MAP kinases: charting the regulatory pathways. Science 1992. 257: 1355-1357.
29. Firpo, E., Koff, A., Salomon, M. J. and Roberts, J. M., Inactivation of a Cdk2 inhibitor during IL-1 induced proliferation of human T lymphocytes. Mol. Cell Biol. 1994. 14: 4889-4901.
30. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R. and Roberts, J. M., Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994. 372: 570-573.
31. Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M. and Ho, D. D., Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997. 188-191.
32. Chun, T. W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., Kuo, Y. H., Brookmeyer, R., Zeiger, M. A., Barditch-Crovo, P. and Siliciano, R. F., Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997. 387: 183-188.
33. Dimitrov, D. S., How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 1997. 91: 721-730.
34. Goldman, F., Crabtree, J., Hollenback, C. and Koretzky, G., Sequestration of p56(lck) by gp120, a model for TCR desensitization. J. Immunol. 1997. 158: 2017-2024.
35. Mittler, R. S. and Hoffmann, M. K., Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 1989. 245: 1380-1382.
36. Oyaizu, N., Chirmule, N., Kalyanaraman, V. S., Hall, W. W., Pahwa, R., Shuster, M. and Pahwa, S., Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 1990. 87: 2379-2388.
37. Liegler, T. J. and Stites, D. P., HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J. Acquir. Immune Defic. Syndr. 1994. 7: 340-348.
38. Tuosto, L., Piazza, C., Moretti, S., Modesti, A., Greenlaw, R., Lechler, R., Lombardi, G. and Piccolella, E., Ligation of either CD2 or CD28 rescues CD4+ T cells from HIV-gp120-induced apoptosis. Eur. J. Immunol. 1995. 25: 2917-2922.
39. Faith, A., Yssel, H., O'Hehir, R. E. and Lamb, J. R., Reversal of the inhibitory effects of HIV-gp120 on CD4+ T cells by stimulation through the CD28 pathway. Clin. Exp. Immunol. 1996. 105: 225-230.
40. Quian, D. and Weiss, A., T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 1997. 9: 205-212.
41. Jabada, N., Pallier, A., Jauliac, S., Fisher, A. and Hivroz, C., gp160 of HIV or anti-CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes. Eur. J. Immunol. 1997. 27: 397-404.
42. Hofmann, B., Nishanian, P., Nguyen, T., Insixiengmay, P. and Fahey, J. L., Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA 1993. 90: 6676-6680.
43. kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 1997. 15: 629-637.
44. kip1. EMBO J. 1997. 16: 5334-5344.
45. kip1) of cyclin-dependent kinase 4 activation. Cell 1994. 79: 487-496.
46. Frearson, J. A. and Alexander, D. R., Protein tyrosine phosphatases in T-cell development, apoptosis and signalling. Immunol. Today 1996. 17: 385-391.
47. Leitenberg, D., Novak, T. J., Farber, D., Smith, B. R. and Bottomly, K., The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 1996. 183: 249-259.
48. Stoiber, H., Pinter, C., Siccardi, A. G., Clivio, A. and Dierich, M. P., Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. 1996. 183: 307-310.
49. Purtscher, M., Trkola, A., Grassauer, A., Schulz, P. M., Klima, A., Dopper, A., Gruber, G., Buchacher, A., Muster, T. and Katinger, H., Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS 1996. 10: 587-593.